Listed biotechnology firm e-therapeutics has raised £13.5 million in a share placing backed by M&G Investment Management, an institutional investor and existing shareholder of the company. The Newcastle University spinout seems to be on an upward trajectory with its platform enabling more efficient drug discovery after CEO Ali Mortazavi – former long-time CEO of Silence … Continue reading Drug discovery platform wins further institutional backing